DOES COST-EFFECTIVENESS ANALYSIS DISCRIMINATE AGAINST PATIENTS WITH SHORTER LIFE EXPECTANCY?

被引：0
|
作者：
Paulden, M. [1 ]
Culyer, A. J. [1 ]
机构：
[1] Univ Toronto, Toronto, ON, Canada
来源：
VALUE IN HEALTH | 2011年 / 14卷 / 03期
关键词：
D O I：
10.1016/j.jval.2011.02.072
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A12 / A12
页数：1
相关论文
共 50 条
  • [1] INCREASING LIFE EXPECTANCY: IMPLICATIONS FOR COST-EFFECTIVENESS ANALYSIS
    Majer, I. M.
    Heeg, B.
    VALUE IN HEALTH, 2012, 15 (07) : A468 - A468
  • [2] Does Cost Effectiveness Analysis Unfairly Discriminate against People with Disabilities?
    Bognar, Greg
    JOURNAL OF APPLIED PHILOSOPHY, 2010, 27 (04) : 394 - 408
  • [3] Do Quality-Adjusted Life Years Discriminate Against the Elderly? An Empirical Analysis of Published Cost-Effectiveness Analyses
    Xie, Feng
    Zhou, Ting
    Humphries, Brittany
    Neumann, Peter J.
    VALUE IN HEALTH, 2024, 27 (06) : 706 - 712
  • [4] Cost-Effectiveness of Oral Bisphosphonates for Osteoporosis at Different Ages and Levels of Life Expectancy
    Pham, Annalise N.
    Datta, Santanu K.
    Weber, Thomas J.
    Walter, Louise C.
    Colon-Emeric, Cathleen S.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2011, 59 (09) : 1642 - 1649
  • [5] Societal discounting of health effects in cost-effectiveness analyses - The influence of life expectancy
    Polinder, S
    Meerding, WJ
    van Exel, J
    Brouwer, W
    PHARMACOECONOMICS, 2005, 23 (08) : 791 - 802
  • [6] Effect of Patient's Life Expectancy on the Cost-effectiveness of Treatment for Ocular Hypertension
    Kymes, Steven M.
    Plotzke, Michael R.
    Kass, Michael A.
    Boland, Michael V.
    Gordon, Mae O.
    ARCHIVES OF OPHTHALMOLOGY, 2010, 128 (05) : 613 - 618
  • [7] Societal discounting of health effects in cost-effectiveness analysesThe influence of life expectancy
    Suzanne Polinder
    Willem Jan Meerding
    Job van Exel
    Werner Brouwer
    PharmacoEconomics, 2005, 23 : 791 - 802
  • [8] Cost-effectiveness analysis of palliative care of cancer patients in the end of life
    Lamfre, Laura
    Hasdeu, Santiago
    Coller, Maria
    Tripodoro, Vilma
    CADERNOS DE SAUDE PUBLICA, 2023, 39 (02):
  • [9] A new method for expressing survival and life expectancy in lifetime cost-effectiveness studies that evaluate cancer patients (review)
    Messori, A
    Trippoli, S
    ONCOLOGY REPORTS, 1999, 6 (05) : 1135 - 1141
  • [10] Cost-effectiveness of Oral Bisphosphonates for Osteoporosis at Different Ages and Levels of Life Expectancy.
    Pham, A.
    Datta, S.
    Weber, T.
    Walter, L.
    Colon-Emeric, C.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2010, 58 : 97 - 98
12345